Nitazoxanide and Lansoprazole Based Regimens for H. Pylori Management
Condition: Helicobacter Pylori Interventions: Drug: Naïve patients - ACO therapy; Drug: Naïve patients - LNDL therapy; Drug: Naïve patients - MNDL therapy; Drug: Treatment-experienced patients- LNDL therapy; Drug: Treatment-experienced patients- MNDL therapy Sponsors: National Liver Institute, Egypt; Future pharmaceutical industries Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2022 Category: Research Source Type: clinical trials
A Study in Patients With Reflux Esophagitis to Investigate Safety, Tolerability, and Healing Rates After 4 Weeks Treatment of X842 or Lansoprazole and Symptom Pattern During Subsequent 4 Weeks Treatment With Lansoprazole
Condition: Reflux Esophagitis Interventions: Drug: X842; Drug: X842 Dummy; Drug: Lansoprazole; Drug: Lansoprazole Dummy Sponsors: Cinclus Pharma AG; Parexel Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 24, 2021 Category: Research Source Type: clinical trials